Visual Field Loss in Patients With Diabetes in the Absence of Clinically-Detectable Vascular Retinopathy in a Nationally Representative Survey | Zendy

Yicheng K. Bao | Zendy; Yan Yan | Zendy; Mae O. Gordon | Zendy; Janet B. McGill | Zendy; Michael A. Kass | Zendy; Rithwick Rajagopal | Zendy

Open Access

Visual Field Loss in Patients With Diabetes in the Absence of Clinically-Detectable Vascular Retinopathy in a Nationally Representative Survey

Author(s) -

Yicheng K. Bao,

Yan Yan,

Mae O. Gordon,

Janet B. McGill,

Michael A. Kass,

Rithwick Rajagopal

Publication year - 2019

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.19-28063

Subject(s) - medicine , diabetic retinopathy , diabetes mellitus , glycated hemoglobin , retinopathy , odds ratio , glaucoma , fundus photography , ophthalmology , visual field , confidence interval , fundus (uterus) , national health and nutrition examination survey , visual acuity , type 2 diabetes , fluorescein angiography , population , endocrinology , environmental health

Neuroretinopathy is increasingly being recognized as an independent cause of vision loss in diabetes. Visual field loss, as detected by frequency doubling technology (FDT)-based visual perimetry, is a sign of neuroretinopathy and occurs in early stages of diabetic retinopathy (DR). Here, we hypothesized that FDT visual field testing could identify patients with diabetic neuroretinopathy in the absence of clinically detectable microvascular DR.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research